[1]
“Sympatho-adrenal dysregulation and clinical manifestations of angiogenic activity in patients with secondary neovascular glaucoma”, Ukr. j. ophthalmol. , no. 3, pp. 22–30, Jun. 2026, doi: 10.31288/Ukr.j.ophthalmol.202632230.